GeDP PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
GeDP PHARMA
Largest movements
- Tangible fixed assets +€44,267
up €44,267 (+8.2%), from €542,858 to €587,125
of which Land and buildings: +€42,920
- Receivables within one year +€35,070
up €35,070 (+235.7%), from €14,876 to €49,946
- Cash -€24,358
down €24,358 (-41.1%), from €59,278 to €34,920
mainly Investment in fixed assets (net) (-€75,005) and Receivables within one year (-€35,070)
- Reserves +€27,505
up €27,505 (+1942.6%), from €1,416 to €28,920
of which Tax-exempt reserves: +€25,698
- Financial income +€52,328
up €52,328 (+328.1%), from €15,950 to €68,278
- Depreciation +€23,427
up €23,427 (+320.4%), from €7,312 to €30,738
- Gross operating margin +€8,302
up €8,302 (+23.0%), from €36,090 to €44,392
- Other operating charges +€6,193
up €6,193 (+1206.4%), from €513 to €6,706
- Taxes +€5,808
up €5,808 (+130.0%), from €4,468 to €10,276
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,630,110 | €1,685,089 | +€54,979 | +3.4% |
| Fixed assets | 21/28 | €1,555,956 | €1,600,223 | +€44,267 | +2.8% |
| Tangible fixed assets | 22/27 | €542,858 | €587,125 | +€44,267 | +8.2% |
| Land and buildings | 22 | €496,293 | €539,213 | +€42,920 | +8.6% |
| Furniture and vehicles | 24 | €46,564 | €47,912 | +€1,347 | +2.9% |
| Financial fixed assets | 28 | €1,013,098 | €1,013,098 | = | 0.0% |
| Current assets | 29/58 | €74,154 | €84,867 | +€10,712 | +14.4% |
| Amounts receivable within one year | 40/41 | €14,876 | €49,946 | +€35,070 | +235.7% |
| Trade receivables | 40 | €14,876 | €49,946 | +€35,070 | +235.7% |
| Cash at bank and in hand | 54/58 | €59,278 | €34,920 | -€24,358 | -41.1% |
| Total equity and liabilities | 10/49 | €1,630,110 | €1,685,089 | +€54,979 | +3.4% |
| Equity | 10/15 | €37,114 | €73,280 | +€36,166 | +97.4% |
| Contributions | 10/11 | €10,000 | €10,000 | = | 0.0% |
| Capital | 10 | €10,000 | €10,000 | = | 0.0% |
| Issued capital | 100 | €10,000 | €10,000 | = | 0.0% |
| Reserves | 13 | €1,416 | €28,920 | +€27,505 | +1942.6% |
| Non-distributable reserves | 130/1 | €1,416 | €3,223 | +€1,807 | +127.6% |
| Legal reserve | 130 | €1,416 | €3,223 | +€1,807 | +127.6% |
| Tax-exempt reserves | 132 | - | €25,698 | +€25,698 | |
| Profit (loss) carried forward | 14 | €25,698 | €34,360 | +€8,662 | +33.7% |
| Amounts payable | 17/49 | €1,592,997 | €1,611,809 | +€18,813 | +1.2% |
| Amounts payable after more than one year | 17 | €1,468,551 | €1,481,954 | +€13,403 | +0.9% |
| Financial debts | 170/4 | €1,468,551 | €1,481,954 | +€13,403 | +0.9% |
| Amounts payable within one year | 42/48 | €124,446 | €129,855 | +€5,410 | +4.3% |
| Current portion of amounts payable after more than one year | 42 | €30,755 | €29,937 | -€818 | -2.7% |
| Trade debts | 44 | €14,798 | €4,764 | -€10,034 | -67.8% |
| Suppliers | 440/4 | €14,798 | €4,764 | -€10,034 | -67.8% |
| Taxes, remuneration and social security | 45 | €874 | €14,189 | +€13,316 | +1524.3% |
| Taxes | 450/3 | €491 | €12,837 | +€12,346 | +2514.2% |
| Remuneration and social security | 454/9 | €383 | €1,353 | +€970 | +253.7% |
| Other amounts payable | 47/48 | €78,019 | €80,965 | +€2,946 | +3.8% |
| Remuneration, social security and pensions | 62 | €1,224 | €5,601 | +€4,377 | +357.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €7,312 | €30,738 | +€23,427 | +320.4% |
| Other operating charges | 640/8 | €513 | €6,706 | +€6,193 | +1206.4% |
| Gross operating margin | 9900 | €36,090 | €44,392 | +€8,302 | +23.0% |
| Operating profit (loss) | 9901 | €27,041 | €1,347 | -€25,694 | -95.0% |
| Financial income | 75/76B | €15,950 | €68,278 | +€52,328 | +328.1% |
| Recurring financial income | 75 | €15,950 | €68,278 | +€52,328 | +328.1% |
| Financial charges | 65/66B | €21,701 | €23,183 | +€1,483 | +6.8% |
| Recurring financial charges | 65 | €21,701 | €23,183 | +€1,483 | +6.8% |
| Profit (loss) for the period before taxes | 9903 | €21,291 | €46,442 | +€25,151 | +118.1% |
| Income taxes | 67/77 | €4,468 | €10,276 | +€5,808 | +130.0% |
| Profit (loss) for the period | 9904 | €16,823 | €36,166 | +€19,343 | +115.0% |
| Profit (loss) for the period to be appropriated | 9905 | €16,823 | €36,166 | +€19,343 | +115.0% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 4 October 2026 via checked.be.